Table 3.
Factors related to the receipt of adjuvant therapy controlling for the competing risk of death
| Multivariate analysis A | Multivariate analysis B | |||||
|---|---|---|---|---|---|---|
| SHR | 95% CI | p-value | SHR | 95% CI | p-value | |
| Anastomotic leak (ref = no leak) | 0.7 | 0.45–1.09 | 0.12 | 0.68 | 0.46–1.01 | 0.06 |
| DLI (ref = no DLI) | 1.5 | 1.09–2.06 | 0.01 | 1.28 | 0.93–1.76 | 0.13 |
| Age | 0.97 | 0.97–0.98 | < 0.001 | 0.97 | 0.97–0.98 | < 0.001 |
| Male sex (ref = female sex) | 1.04 | 0.68–1.58 | 0.86 | 1.01 | 0.72–1.44 | 0.94 |
| Weight loss (ref = no preoperative weight loss) | 0.86 | 0.64–1.16 | 0.32 | |||
| Neoadjuvant CRT (ref = no neoadjuvant CRT) | 0.71 | 0.58–0.88 | 0.002 | |||
| Active smoking (ref = non-smokers) | 1.37 | 1.25–1.50 | < 0.001 | |||
Bolded values indicated statistical significance
DLI diverting loop ileostomy, SHR subhazard ratio, CI confidence interval, CRT chemoradiation, ref reference